近日， 中核粒子医疗科技有限公司（以下简称"中核粒子"） 宣布完成 首轮逾亿元股权融资 。 本轮融资由中 核产业基金管理有限公司（以下简称"中核基金"）领投，国新创投基金跟投，并通过北京产权交易所公开挂牌 增资方式顺利完成。 本轮资金将主要用于公司三大产品线的研发突破、核心器械的工程化推进、注册与临床试验布局，以及市场端 的示范推广，为未来产品上市奠定更稳固的基础。 # 公 司介绍 中核粒子成立于 2019 年，总部位于北京，由中国宝原投资有限公司控股，是中国核工业集团有限公司在核医 疗装备领域布局的自主研发平台。近年来，公司聚焦"责任、安全、创新、协同"的价值理念，以"强核助医、 守护健康"为使命，围绕肿瘤诊断与治疗领域打造全栈式产品体系，愿景是成为国际核医疗装备发展的引领 者。 # 产 品介绍 中核粒子的三条产品线覆盖核医疗装备的核心环节：BNCT 治疗装备、核医学影像设备 SPECT，以及医用电 子直线加速器。目前三类产品均进入关键的研发攻关与示范应用阶段，为未来注册、生产与规模化落地奠定了 基础。 （1）BNCT 装备：面向难治性肿瘤的前沿放疗技术 硼中子俘获治疗 BNCT（Boron Neutron ...

Core Insights - The article highlights the advancements in proton therapy technology by China General Nuclear Power Group (CGN) and its subsidiary, CGN Medical Technology, which has established the first commercial multi-room proton therapy system production base in China [1] - The 230 MeV cyclotron, a key component of the proton therapy system, has been successfully produced, with three units completed in the first year of operation [1] - The company aims to achieve a world-class nuclear medical industry by 2030, leveraging local research and manufacturing capabilities in Mianyang, Sichuan [1] Company Overview - CGN Medical Technology has adopted a strategy of "introduction, digestion, absorption, and re-innovation" to develop its proton therapy systems, following successful practices in China's nuclear power sector [1] - The proton therapy system consists of 227 main devices and approximately 155,000 components, showcasing its complexity and technological sophistication [1] - The company has formed partnerships with over 80 upstream and downstream enterprises in the industry, promoting continuous technological innovation [1] Industry Context - The Sichuan province has implemented supportive policies to foster the development of the nuclear medical industry, aiming to establish itself as a global leader in medical isotope production and nuclear medical equipment manufacturing by 2030 [1] - The region's strong research and manufacturing foundation, exemplified by institutions like the China Engineering Physics Research Institute, contributes to the rapid growth of the nuclear medical sector in Mianyang [1] - The article emphasizes the potential for China to export its advanced imaging and treatment technologies internationally, marking a significant step in the global nuclear medical landscape [1]